Sandra D Corry, CRNA | |
2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404-3239 | |
(423) 698-3309 | |
(423) 624-6355 |
Full Name | Sandra D Corry |
---|---|
Gender | Female |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 27 Years |
Location | 2341 Mccallie Ave, Chattanooga, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629044383 | NPI | - | NPPES |
3067919 | Other | TN | BCBS |
3626012 | Medicaid | TN |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Healthcare System, Inc | Chattanooga, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
American Anesthesiology Of Tennessee Pc | 9931001922 | 382 |
News Archive
Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.
Heavy alcohol drinkers are at high risk for suffering intracerebral hemorrhage at a relatively young age, say researchers.
Bringing three powerful chemical groups together offers new possibilities in drug development.A new chemical route for potential antimalarial compounds has been pioneered by chemists at KAUST. It offers hope for improved treatment of malaria, a disease that kills more than a million people each year
Researchers from LSTM's Research Centre for Drugs and Diagnostics have found a way of significantly reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days. By targeting Wolbachia, a bacterial symbiont that the filarial parasites need to live, the team has discovered a drug synergy that enables effective treatment over a shorter time.
› Verified 9 days ago
Entity Name | Anesthesiologists Associated Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043278443 PECOS PAC ID: 8022920438 Enrollment ID: O20031105000540 |
News Archive
Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.
Heavy alcohol drinkers are at high risk for suffering intracerebral hemorrhage at a relatively young age, say researchers.
Bringing three powerful chemical groups together offers new possibilities in drug development.A new chemical route for potential antimalarial compounds has been pioneered by chemists at KAUST. It offers hope for improved treatment of malaria, a disease that kills more than a million people each year
Researchers from LSTM's Research Centre for Drugs and Diagnostics have found a way of significantly reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days. By targeting Wolbachia, a bacterial symbiont that the filarial parasites need to live, the team has discovered a drug synergy that enables effective treatment over a shorter time.
› Verified 9 days ago
Entity Name | American Anesthesiology Of Tennessee Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609822998 PECOS PAC ID: 9931001922 Enrollment ID: O20040713001364 |
News Archive
Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.
Heavy alcohol drinkers are at high risk for suffering intracerebral hemorrhage at a relatively young age, say researchers.
Bringing three powerful chemical groups together offers new possibilities in drug development.A new chemical route for potential antimalarial compounds has been pioneered by chemists at KAUST. It offers hope for improved treatment of malaria, a disease that kills more than a million people each year
Researchers from LSTM's Research Centre for Drugs and Diagnostics have found a way of significantly reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days. By targeting Wolbachia, a bacterial symbiont that the filarial parasites need to live, the team has discovered a drug synergy that enables effective treatment over a shorter time.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Sandra D Corry, CRNA Po Box 3549, Chattanooga, TN 37404-0549 Ph: (423) 698-3309 | Sandra D Corry, CRNA 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404-3239 Ph: (423) 698-3309 |
News Archive
Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient's ability to metabolize some medications to help inform discussions with a health care provider.
Heavy alcohol drinkers are at high risk for suffering intracerebral hemorrhage at a relatively young age, say researchers.
Bringing three powerful chemical groups together offers new possibilities in drug development.A new chemical route for potential antimalarial compounds has been pioneered by chemists at KAUST. It offers hope for improved treatment of malaria, a disease that kills more than a million people each year
Researchers from LSTM's Research Centre for Drugs and Diagnostics have found a way of significantly reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days. By targeting Wolbachia, a bacterial symbiont that the filarial parasites need to live, the team has discovered a drug synergy that enables effective treatment over a shorter time.
› Verified 9 days ago
Megan A Spears, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-602-8400 Fax: 423-602-8401 | |
Mr. Edward Brian Hallock, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-602-8400 Fax: 423-602-8401 | |
Amy T. Garner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Eun Hyea Godbold, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2525 Desales Ave, Chattanooga, TN 37404 Phone: 423-495-2525 | |
Christina Michelle Robinson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 979 E 3rd St Ste C235, Chattanooga, TN 37403 Phone: 423-602-8400 | |
Mrs. Julie D Baggett, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2341 Mccallie Ave, Suite 402, Chattanooga, TN 37404 Phone: 423-698-3309 Fax: 423-624-6355 | |
Susan L Battles, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 975 E Third St, Chattanooga, TN 37403 Phone: 423-778-7608 Fax: 423-778-2360 |